Literature DB >> 35020926

Targeting glutamine addiction in meningioma.

Anh Nhat Tran1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35020926      PMCID： PMC8972203          DOI： 10.1093/neuonc/noac007

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  8 in total

1.  Glutaminase inhibitor CB-839 increases radiation sensitivity of lung tumor cells and human lung tumor xenografts in mice.

Authors:  Gunnar Boysen; Azemat Jamshidi-Parsian; Mary A Davis; Eric R Siegel; Christine M Simecka; Rajshekhar A Kore; Ruud P M Dings; Robert J Griffin
Journal:  Int J Radiat Biol       Date:  2019-01-15       Impact factor: 2.694

Review 2.  Medical therapies for meningiomas.

Authors:  Patrick Y Wen; Eudocia Quant; Jan Drappatz; Rameen Beroukhim; Andrew D Norden
Journal:  J Neurooncol       Date:  2010-09-04       Impact factor: 4.130

3.  Glutamine anaplerosis is required for amino acid biosynthesis in human meningiomas.

Authors:  Omkar B Ijare; Shashank Hambarde; Fabio Henrique Brasil da Costa; Sophie Lopez; Martyn A Sharpe; Santosh A Helekar; Gilbert Hangel; Wolfgang Bogner; Georg Widhalm; Robert M Bachoo; David S Baskin; Kumar Pichumani
Journal:  Neuro Oncol       Date:  2022-04-01       Impact factor: 13.029

Review 4.  Recent developments in chemotherapy for meningiomas: a review.

Authors:  Alan A Moazzam; Naveed Wagle; Gabriel Zada
Journal:  Neurosurg Focus       Date:  2013-12       Impact factor: 4.047

5.  Glutaminase Inhibitors Induce Thiol-Mediated Oxidative Stress and Radiosensitization in Treatment-Resistant Cervical Cancers.

Authors:  Ramachandran Rashmi; Kay Jayachandran; Jin Zhang; Vishnu Menon; Naoshad Muhammad; Michael Zahner; Fiona Ruiz; Sisi Zhang; Kevin Cho; Yuting Wang; Xiaojing Huang; Yi Huang; Michael L McCormick; Buck E Rogers; Douglas R Spitz; Gary J Patti; Julie K Schwarz
Journal:  Mol Cancer Ther       Date:  2020-10-21       Impact factor: 6.261

Review 6.  Enhancing the Efficacy of Glutamine Metabolism Inhibitors in Cancer Therapy.

Authors:  Wen-Hsuan Yang; Yijian Qiu; Olivia Stamatatos; Tobias Janowitz; Michael J Lukey
Journal:  Trends Cancer       Date:  2021-05-18

7.  Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer.

Authors:  Maria T Grinde; Bylgja Hilmarsdottir; Hanna Maja Tunset; Ida Marie Henriksen; Jana Kim; Mads H Haugen; Morten Beck Rye; Gunhild M Mælandsmo; Siver A Moestue
Journal:  Breast Cancer Res       Date:  2019-05-14       Impact factor: 6.466

8.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017.

Authors:  Quinn T Ostrom; Nirav Patil; Gino Cioffi; Kristin Waite; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2020-10-30       Impact factor: 12.300
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.